Everstone buys controlling interest in Softgel Healthcare for scaled operations

Date: 2022-09-15   Author: Saipriya Iyer  Category: #news

Everstone buys controlling interest in Softgel Healthcare for scaled operations

Everstone Capital, a Singapore-based private equity division of the Everstone Group, has recently announced that it has acquired a controlling stake in SHPL Softgel Healthcare or SHPL, a well-known pharma-based firm.

With this partnership, SHPL will become a diversified, scaled, and globally recognized contract research, manufacturing, and development organization in India backed by Everstone’s leading strategic resources.

For the unversed, SHPL, headquartered in Chennai, is a part of the Madras Pharma Group, a leading pharmaceutical company that owns 8 manufacturing facilities that encompass all dosage forms.

It is also well recognized for developing, researching, and manufacturing probiotics and soft gelatin capsules. The company also includes customers from the Americas, Africa, India, and Asia, with around 80% of its sales being in exports.

Apparently, it houses a cutting-edge manufacturing facility in Chennai, that conforms to globally recognized registrations and certifications like USFDA, TGA, Health Canada, and EU-GMP, among others.

Expressing his views on the investment, Sameer Sain, CEO, and Co-founder, Everstone Group, stated that the firm is delighted to collaborate with SPHL, Mr A. M. Sulaiman, Founder-Chairman of the Madras Group, and the team headed by Dr Vijay Alagappan.

Sameer further stated that the firm is in a strong position to become a leader in the CDMO segment, given its solid R&D capabilities and ability to manufacture products in progressive dosage forms.

As per sources, the firm believes that Everstone’s value creation playbook will assist SHPL in recognizing its goals and help the company to grow.

Meanwhile, Managing Directors, Dr Arjun Oberoi and Puncham Mukim are expected to join the SHFL board.

Mr Sulaiman quoted that the firm is delighted to collaborate with Everstone as SHPL takes a step ahead into the expanding phase in the business.

Sulaiman also added that Everstone would drive organizational learning by offering best-in-class products and services to the customers and becoming a manufacturer of choice.

It has also been reported that Veda Corporate Advisors was the first ever financial advisor to SHPL and its shareholders.

Source credit - https://www.prnewswire.com/in/news-releases/everstone-acquires-controlling-stake-in-softgel-healthcare-837474069.html



About Author


Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Genetic Testing Market by Type, Application, Element - Global Trends and Forecast to 2027

Author: Rahul Varpe

Global market insights declares the publication of its latest research report, with the title ‘global Genetic Testing market’. This report sheds light on the analysis of the industry challenges, growth...


Dental CAD/CAM Market, Share, Growth, Trends and Forecast to 2027: Global Market Insights

Author: Rahul Varpe

Global market insights declares the publication of its latest research report, with the title ‘global Dental CAD/CAM Drugs market’. This report sheds light on the analysis of the industry challenges, g...


Companion Animal Drugs Market Research Report Analysis and Forecasts to 2027

Author: Rahul Varpe

Global market insights declares the publication of its latest research report, with the title ‘global Companion Animal Drugs market’. This report sheds light on the analysis of the industry challe...